340b
(5)
PharmaForce and the money hiding in the paperwork
A prescription can be filled and a discount still missed. PharmaForce builds the software and services that help hospitals follow the evidence - and keep more of their eligible 340B savings.
Sentry Data and the $400 million paper trail
A hospital can dispense the right drug and still buy its replacement on the wrong terms. Sentry Data built a business connecting those two moments - and Craneware paid $400 million to bring it inside.
Kalderos Found a $1 Billion Leak in America’s Drug-Discount Plumbing
Drug discounts are supposed to lower costs. The data underneath them is so fragmented that the same prescription can trigger multiple concessions. Kalderos built the reconciliation layer - and in 2026, Model N bought it.
Model N
Model N is a Redwood City-based enterprise software company that builds cloud revenue-management systems for pharmaceutical, medtech, semiconductor, and high-tech manufacturers. Its Revenue Cloud automates pricing, quoting, contracting, rebates, incentives, and regulatory compliance - the commercial machinery that governs how life sciences and high-tech companies book and protect their top line. Founded in 1999 and taken public in 2013, Model N was acquired by Vista Equity Partners in 2024 for $1.25 billion and now serves 150+ leading brands across more than 120 countries.
Plenful
Plenful is a San Francisco-based AI workflow automation company building software that takes the busywork out of pharmacy and healthcare operations. Founded in 2021 by former pharmacy operator Joy Liu, the company helps health systems, specialty pharmacies, and infusion teams automate 340B audits, rebate management, prior authorization, and patient intake - work that has long been trapped in PDFs, faxes, and spreadsheets.